Details for Patent: 5,670,524

✉ Email this page to a colleague

Summary for Patent: 5,670,524

Title:	Methods and compositions for the treatment of pain utilizing ropivacaine
Abstract:	Use of a pharmaceutically acceptable salt of ropivacaine for the manufacture of a pharmaceutical preparation with sensoric block and minimal motor blockade.
Inventor(s):	Eek; Arne Torsten (Trosa, SE)
Assignee:	Astra AB (SE)
Application Number:	08/256,319
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 5,670,524

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,670,524

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	9302218	Jun 28, 1993

PCT Information
PCT Filed	May 26, 1994	PCT Application Number:	PCT/SE94/00496
PCT Publication Date:	January 05, 1995	PCT Publication Number:	WO95/00148

International Family Members for US Patent 5,670,524

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	216237	⤷ Sign Up
Australia	692161	⤷ Sign Up
Australia	7086694	⤷ Sign Up
Brazil	9406865	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.